OCT 14, 2020 7:30 AM PDT

Self-Healing Microcapsules Make Promising Leukemia Vaccines

WRITTEN BY: Tara Fernandez

Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic system.  It is characterized by rapid, out-of-control growth of abnormal cells in these tissues and accounts for around four percent of all new cancer cases in the United States.

A recent study published in Nature Biomedical Engineering details how researchers are a step closer towards a therapeutic vaccine against leukemia. Though previous works have shown promise in preventing the development of leukemia through vaccination, the clinical performance of such experimental therapies has been underwhelming so far. In part, this is due to shortcomings of the vaccine’s delivery system.

Professor Li Yuhua, from China’s Zhujiang Hospital was among the scientists leading the study and said: "Our clinical findings revealed the high expression of EPS8 and PD-1/PD-L1 in leukemia patients, which could be respectively used as a new type of leukemia antigen and a checkpoint target for a leukemia vaccine."

The team designed a novel self-healing microcapsule that contains a cargo of epitope peptides and an antibody against PD-1. These microcapsules are made of polylactic acid, an FDA-approved biomaterial that is regarded as a reference material for injectable microparticles. What’s special about these newly-developed microcapsules is their ability to efficiently load the vaccine’s active ingredients and subsequently “self heal”, sealing them in before releasing the vaccine over a prolonged period once injected into the body.

The microcapsules performed considerably better than currently-available adjuvants in a variety of leukemia therapeutic models, highlighting their exciting potential in a clinical setting.

"With the advantages of FDA-approved polylactic acid material, convenience in preparing the vaccine formulation, diversity of vaccine components, and excellent therapeutic effect, the microcapsule-based vaccine exhibits great potential for clinical translation," said Professor Ma Guanghui from the Institute of Process Engineering (IPE) of Chinese Academy of Sciences, another author of the paper.

Sources: Nature Biomedical Engineering, Medical Xpress.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 08, 2020
Health & Medicine
The Myths About CBD and Coronavirus
JUL 08, 2020
The Myths About CBD and Coronavirus
Research collected over the last 20 years suggests that cannabidiol – the primary cannabinoid in CBD oil – h ...
JUL 30, 2020
Immunology
Sunshine Could Lower Your Risk of Developing MS
JUL 30, 2020
Sunshine Could Lower Your Risk of Developing MS
In multiple sclerosis, or MS, the insulating sheaths around nerve cells in the brain and spinal cord called myelin becom ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
SEP 20, 2020
Microbiology
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
SEP 20, 2020
Middle-Aged Adults Might Always be Susceptible to H3N2 Flu
People born in the late 1960s or 1970s might be perpetually susceptible to the H3N2 influenza virus, according to new re ...
SEP 21, 2020
Cell & Molecular Biology
The Hormones We Have at Birth Are Linked to Disease Throughout Life
SEP 21, 2020
The Hormones We Have at Birth Are Linked to Disease Throughout Life
New work may help explain why some autoimmune or immune-related diseases are more common in women, who are more likely t ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
Loading Comments...